20
Jan

After an unprecedented surge of biotech IPOs in 2014, the industry’s eyes have turned to gene therapy upstart Spark Therapeutics, poised to pull off the biggest IPO of the new year.

…read more

Source: Spark lays out a $108M IPO and tests the biotech boom’s longevity

    

0 No comments